XML 14 R4.htm IDEA: XBRL DOCUMENT v3.20.4
Condensed Consolidated Statements of Operations - USD ($)
 3 Months Ended 9 Months Ended
Dec. 31, 2020
Dec. 30, 2019
Dec. 31, 2020
Dec. 31, 2019
Operating Expenses:        
Research and development $ 1,086,669 $ 608,019 $ 3,150,149 $ 1,945,043
General and administration expenses 783,898 527,829 2,453,808 1,486,386
Total operating expenses 1,870,567 1,135,848 5,603,957 3,431,429
Loss from operations (1,870,567) (1,135,848) (5,603,957) (3,431,429)
Other Income:        
Interest income 22 2,331 126 28,148
Loss before income taxes (1,870,545) (1,133,517) (5,603,831) (3,403,281)
Provision for income taxes 0 0 1,600 0
Net loss $ (1,870,545) $ (1,133,517) $ (5,605,431) $ (3,403,281)
Net Loss Per Share:        
Basic and diluted $ (0.10) $ (0.06) $ (0.30) $ (0.19)
Weighted Average Number of Shares Outstanding:        
Basic and diluted 18,747,112 17,870,261 18,562,577 17,862,625